Difference between revisions of "Adoption of Clinical Decision support in Multimorbidity: A Systematic Review"
Liyu Geresu (Talk | contribs) m |
Liyu Geresu (Talk | contribs) m |
||
| Line 7: | Line 7: | ||
• Obstacles in continuity of care, confusing self-management information and | • Obstacles in continuity of care, confusing self-management information and | ||
• Medication error | • Medication error | ||
| − | Objective | + | [[Objective]] |
The objective of the literature is to assess the extent of [[CDS]] adoption in area of multimorbidity. | The objective of the literature is to assess the extent of [[CDS]] adoption in area of multimorbidity. | ||
| − | + | [[Methods]] | |
| − | Methods | + | For this literature reviewers searched database such as Scopus and PubMed by combining terms and synonyms including: multimorbidity and comorbidity, polypharmacy and CDS. Relevant articles to the review were further analyzed. |
| − | + | [[Result]] | |
| − | + | Out of the 50 articles that were selected for final review only 20 studies were included in the article. | |
| − | Result | + | [[Discussion]] |
| − | + | The review asserts that CDS is not fully invested in the area of multimorbidity. It also warns, CDS intervention that doesn’t consider the interaction of different clinical conditions within a patient may even result in harm than benefit. However on the brighter side, data needed to build such complex CDS is available in the current [[EMR]]s. | |
| − | + | [[Conclusion]] | |
| − | Discussion | + | Finally Fraccaro et al (2015) concludes, “ multimorbildity is understudied in CDS, yet this is an area of public health and clinical importance that should be a prime target for CDS research” |
| − | + | [[Limitations]] | |
| − | + | ||
| − | Conclusion | + | |
| − | + | ||
| − | + | ||
| − | Limitations | + | |
The limitations of the review are as follows: | The limitations of the review are as follows: | ||
• Only two database were searched, | • Only two database were searched, | ||
| Line 28: | Line 23: | ||
• Reviewers were unable to find article that covers all aspects of CDS, | • Reviewers were unable to find article that covers all aspects of CDS, | ||
• Reviewers didn’t strictly follow the traditional systematic review. | • Reviewers didn’t strictly follow the traditional systematic review. | ||
| − | + | [[Comments]] | |
| − | Comments | + | This review touched an area that is not fully addressed by CDS. Now, it is important to note the need for a refined CDS system that has a capacity to deal with complex multimorbidity conditions that is becoming prevalent as a result of an increasing number of aging populations. |
| − | + | ||
[[Category: Reviews]] | [[Category: Reviews]] | ||
[[Category: CDS]] | [[Category: CDS]] | ||
Revision as of 02:15, 26 March 2015
Background According to Fraccaro et al (2015), the rise in the number of aging population is associated with multiple clinical conditions per patient or known as multiplemorbidity. Even worse, multimorbidity is complex and demanding in nature. To illustrate the complexity, Fraccaro et al (2015) listed some of the potential problems associated with it as follows:
• Interaction between pathologies, • Duplication of tests, • Difficulties in adhering to often conflicting, clinical practice guidelines, • Obstacles in continuity of care, confusing self-management information and • Medication error Objective The objective of the literature is to assess the extent of CDS adoption in area of multimorbidity. Methods For this literature reviewers searched database such as Scopus and PubMed by combining terms and synonyms including: multimorbidity and comorbidity, polypharmacy and CDS. Relevant articles to the review were further analyzed. Result Out of the 50 articles that were selected for final review only 20 studies were included in the article. Discussion The review asserts that CDS is not fully invested in the area of multimorbidity. It also warns, CDS intervention that doesn’t consider the interaction of different clinical conditions within a patient may even result in harm than benefit. However on the brighter side, data needed to build such complex CDS is available in the current EMRs. Conclusion Finally Fraccaro et al (2015) concludes, “ multimorbildity is understudied in CDS, yet this is an area of public health and clinical importance that should be a prime target for CDS research” Limitations The limitations of the review are as follows: • Only two database were searched, • Potentially useful articles may have been missed based on the terms and synonyms used during search, • Reviewers were unable to find article that covers all aspects of CDS, • Reviewers didn’t strictly follow the traditional systematic review. Comments This review touched an area that is not fully addressed by CDS. Now, it is important to note the need for a refined CDS system that has a capacity to deal with complex multimorbidity conditions that is becoming prevalent as a result of an increasing number of aging populations.
